Related Experiment Video
Updated: Jun 28, 2025

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Isolated Celiac Artery Vasculitis Presenting as Ileus in a Patient With Ulcerative Colitis
Sareena Ali1, Meghana Doniparthi2, Nahren Asado3
1Department of Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, IL.
Inflammatory bowel disease (IBD) patients developing vasculitis may not solely be linked to anti-tumor necrosis factor (anti-TNF) therapies. Thiopurines might offer protection against vasculitis in IBD cases.
Area of Science:
- Gastroenterology
- Immunology
- Rheumatology
Background:
- Inflammatory bowel disease (IBD) is associated with vasculitis, potentially presenting as mesenteric ischemia or skin conditions.
- Anti-tumor necrosis factor (anti-TNF) therapies, commonly used for IBD, have been suspected in causing vasculitis.
- Understanding the etiology of vasculitis in IBD is crucial for patient management.
Observation:
- A unique case of ulcerative colitis (UC) patient developed isolated celiac artery vasculitis.
- Symptoms included abdominal pain and ileus, occurring after a reduction in azathioprine dosage.
- The patient was on anti-tumor necrosis factor (anti-TNF) therapy concurrently.
Findings:
- Vasculitis resolved with corticosteroid treatment and an increased azathioprine dosage.
- Anti-tumor necrosis factor (anti-TNF) therapy was continued throughout the treatment period.
- This suggests a potential protective role for thiopurines in preventing vasculitis.
Implications:
- Anti-TNF agents may not be the sole cause of vasculitis in IBD patients.
- Thiopurines could play a protective role against vasculitis in the context of IBD.
- This case broadens the understanding of vasculitis triggers and protective factors in IBD management.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Ulcerative Colitis in IBD

